Mei-Chen Lee1, Shu-Fang Vivienne Wu2, Nan-Chen Hsieh3, Juin-Ming Tsai4. 1. School of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan. 2. School of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan. Electronic address: shufang@ntunhs.edu.tw. 3. Department of Information Management, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan. 4. Department of Long Term Care, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
Abstract
PURPOSE: Chronic kidney disease (CKD) is a condition characterized by the gradual loss of kidney function over time. Self-management programs have been widely applied to chronic disease education programs, which are designed to delay deteriorating kidney functions, preclude depression, and improve quality of life. This study aims to analyze effectiveness of self-management programs in bettering CKD patients' eGFR, mitigating depression symptoms and improving quality of life in randomized control or clinical trials. METHODS: Using key terms, a search was conducted in English-language, peer-reviewed journals on CKD that were published between 2002 and 2014 on databases including CINAHL, Cochrane Library, MEDLINE. The measurable variables included CKD patients' eGFR, depression, and quality of life. Random and fixed effects meta analysis were applied with standard error and correlation based measure of effect size. RESULTS: Eight studies met the inclusion criteria. A self-management program significantly impacted CKD patients' depression and mental quality-of-life dimensions, with an effect size of .29 [95% confidence interval (CI) (0.07, 0.53)] and -.42 [95% CI (-0.75, -0.10)]. However, the intervention of a self-management program had no significant effect on patients' eGFR as well as physical quality-of-life dimensions, with effect sizes of .06 [95% CI (-0.69, 0.81)] and -.16 [95% CI (-0.81, 0.50)]. CONCLUSIONS: Self-management programs of patients with chronic kidney disease can improve the depression and mental quality of life. Aside from providing more objective evidence-based results, this study provides a reference for clinical health care personnel who tend to patients with CKD.
PURPOSE:Chronic kidney disease (CKD) is a condition characterized by the gradual loss of kidney function over time. Self-management programs have been widely applied to chronic disease education programs, which are designed to delay deteriorating kidney functions, preclude depression, and improve quality of life. This study aims to analyze effectiveness of self-management programs in bettering CKDpatients' eGFR, mitigating depression symptoms and improving quality of life in randomized control or clinical trials. METHODS: Using key terms, a search was conducted in English-language, peer-reviewed journals on CKD that were published between 2002 and 2014 on databases including CINAHL, Cochrane Library, MEDLINE. The measurable variables included CKDpatients' eGFR, depression, and quality of life. Random and fixed effects meta analysis were applied with standard error and correlation based measure of effect size. RESULTS: Eight studies met the inclusion criteria. A self-management program significantly impacted CKDpatients' depression and mental quality-of-life dimensions, with an effect size of .29 [95% confidence interval (CI) (0.07, 0.53)] and -.42 [95% CI (-0.75, -0.10)]. However, the intervention of a self-management program had no significant effect on patients' eGFR as well as physical quality-of-life dimensions, with effect sizes of .06 [95% CI (-0.69, 0.81)] and -.16 [95% CI (-0.81, 0.50)]. CONCLUSIONS: Self-management programs of patients with chronic kidney disease can improve the depression and mental quality of life. Aside from providing more objective evidence-based results, this study provides a reference for clinical health care personnel who tend to patients with CKD.
Authors: Luke A Baker; Daniel S March; Thomas J Wilkinson; Roseanne E Billany; Nicolette C Bishop; Ellen M Castle; Joseph Chilcot; Mark D Davies; Matthew P M Graham-Brown; Sharlene A Greenwood; Naushad A Junglee; Archontissa M Kanavaki; Courtney J Lightfoot; Jamie H Macdonald; Gabriella M K Rossetti; Alice C Smith; James O Burton Journal: BMC Nephrol Date: 2022-02-22 Impact factor: 2.388
Authors: Maoliosa Donald; Bhavneet Kaur Kahlon; Heather Beanlands; Sharon Straus; Paul Ronksley; Gwen Herrington; Allison Tong; Allan Grill; Blair Waldvogel; Chantel A Large; Claire L Large; Lori Harwood; Marta Novak; Matthew T James; Meghan Elliott; Nicolas Fernandez; Scott Brimble; Susan Samuel; Brenda R Hemmelgarn Journal: BMJ Open Date: 2018-03-22 Impact factor: 2.692
Authors: Hongxia Shen; Rianne M J J van der Kleij; Paul J M van der Boog; Wenjiao Wang; Xiaoyue Song; Zhengyan Li; Xiaoping Lou; Niels Chavannes Journal: BMJ Open Date: 2021-03-04 Impact factor: 2.692
Authors: Edward Zimbudzi; Clement Lo; Sanjeeva Ranasinha; Gregory Fulcher; Martin Gallagher; Stephen Jan; Peter G Kerr; Helena J Teede; Kevan R Polkinghorne; Grant Russell; Rowan G Walker; Sophia Zoungas Journal: Health Qual Life Outcomes Date: 2018-11-19 Impact factor: 3.186